NTRK Fusion Testing Webinar
NTRK Fusion Testing in Lung Cancer—Another Reason to Implement Broad Molecular Profiling
NTRK gene fusions can drive unregulated cell growth and proliferation in a range of cancer types. Recently, this pathway gained significant focus and attention in precision oncology. Next-Generation Sequencing provides the most comprehensive view across a large number of genes and can identify NTRK gene fusions as well as other relevant alterations, with minimal sample tissue needed. View the webinar to learn:
- Why NTRK fusion testing is becoming important.
- What the different methods are including their pros and cons based on real data from lung cancer testing.
- How developments in precision oncology are changing not only cancer care, but also the way we should approach biomarker testing in our laboratories.
Further Questions?
If you have any questions about using NGS for NTRK fusion detection in your laboratory, be sure to get in touch with one of our repsentatives and we'll be happy to provide the answers you need.
Learn more about Oncomine Solutions
We offer several NGS-based, multibiomarker assays for clinical research designed to simultaneously detect gene fusions, such as NTRK1, NTRK2 and NTRK3, as well as hundreds of DNA and RNA-based genomic alterations associated with cancer. They include: Oncomine Comprehensive Assay, Oncomine Focus Assay, and the Oncomine Childhood Cancer Research Assay.
For Research Use Only. Not for use in diagnostic procedures.
Trademarks | Terms and Conditions | Privacy Notices
© 2021 Thermo Fisher Scientific Inc. All Rights Reserved.
Select Your Location
United Kingdom
United States